RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
Tecentriq was approved by the U.S. Food and Drug Administration (FDA) for some patients with lung cancer. PUBLISHED: OCTOBER 18, 2016. Be the first to discuss this article on CURE's forum.
In 2012, the FDA approved tofacitinib (Xeljanz) a new type of disease-modifying arthritis drug (DMARD). Tofacitinib is approved for patients with moderate-to-severe rheumatoid arthritis who have not been helped by methotrexate.Tofacitinib is the first new DMARD approved in over a decade.ntroduction. Rheumatoid arthritis (RA) is a chronic disease in which various joints in the body are inflamed, leading to swelling, pain, stiffness, and the possible loss of function. Rheumatoid arthritis is an autoimmune disease in which the body's immune system attacks joints and other tissues.